News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
01
2025
-
12
Key brand IP launch from Keyuan Pharmaceutical & Linuo Pharmaceutical! Once upon a time, it was said that a divine beast emerged from Kunlun—its name was the Qilin!
Classification：
行业新闻
Corporate News
Staff Style
Lin is a brand IP image meticulously crafted by Keyuan Pharmaceutical and Linuo Pharmaceutical. The Qilin treads upon auspicious clouds, dispelling all hardships in the human world. The virtues of benevolence, wisdom, and strength symbolized by this auspicious creature closely align with the core spirit of both Keyuan Pharmaceutical and Linuo Pharmaceutical.
Once upon a time, it was said that a divine beast emerged from Kunlun—its name was Qilin. It possessed an imposing and majestic presence, with noble virtue and impeccable integrity. Observing its form, one sees a dragon’s head and a phoenix’s tail, its body adorned with shimmering scales that outshine the sun and moon. Its horn reflects the radiance of the heavens, its eyes hold the wisdom of the stars, and its gait is calm and composed, every glance exuding awe-inspiring power.
When the wind rises, it soars among the clouds and mist, appearing and disappearing high above the nine heavens; when rain falls, it treads lightly upon the waves, emerging and vanishing along the shores of the four seas. Observing its nature, we find it benevolent, gentle, and mild—neither harming humans nor animals, nor trampling upon living creatures. It is undisturbed by thunder, unafraid of fire, filled with compassion, and ever ready to protect all beings. In its moments of concealment and manifestation, it heralds a time of great wisdom and virtue, bringing forth auspicious omens. Thus, in ancient times, people revered it as a divine beast, depicting its form and carving its likeness, seeking blessings and praying for peace and tranquility.
Yet the golden age of the Qilin comes but once in a century. Only those with lofty aspirations can witness its true form; only those of noble character can receive its blessings. When the Qilin spews jade scriptures, sages descend to earth; when the Qilin carries benevolence and righteousness, it manifests itself during the Han and Tang dynasties.
We, born in a prosperous age, inherit the benevolent heart of the Qilin and harbor the noble aspiration to bring salvation to all. With digital intelligence as our wings and artisanal dedication as our soul, we craft medicines to save lives and heal illnesses to bring peace and well-being to the people. Our actions are like the Qilin’s gentle protection of all living beings; our aspirations are as radiant and universal as sunlight illuminating every corner of the world.
A physician’s heart is filled with benevolence, and a pharmacist’s craftmanship is guided by dedication. May the world be blessed everywhere with the auspicious presence of the Qilin, may everyone be spared from the suffering of illness, may health endure forever, and may peace reign supreme throughout the land.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
2026-05-13
On May 13, the 92nd National Pharmaceutical Fair and the 94th China International API, Intermediate, Packaging & Equipment Exhibition (API China) opened in grand style at the Shanghai National Exhibition and Convention Center. As an innovative, publicly listed company in China’s chemical pharmaceutical sector, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ), together with its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., made a high‑profile appearance, showcasing a coordinated approach to APIs and finished dosage forms, a comprehensive end-to-end product portfolio, and strong brand synergy. The company highlighted its robust capabilities in innovative R&D, digital and intelligent manufacturing, green production, global supply chains, and clinical translation, while engaging domestic and international partners to explore emerging industry trends, expand new avenues of collaboration, and co‑create a thriving new ecosystem for the pharmaceutical and healthcare sectors.
2026-05-07
On May 6, Lino Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), held a company-wide meeting in Jinan. Centered on the core principle of “unified strategy across the entire workforce and coordinated action across all business units,” the meeting comprehensively communicated the company’s development strategy and outlined the implementation roadmap, aligning the thinking and building consensus among all employees. With a spirit of concerted effort and synchronized momentum, the meeting charted a new blueprint for the company’s high-quality development.
2026-05-07
Recently, the Jinan Municipal Federation of Trade Unions officially announced the list of winners for the 2025 “Making Contributions in the Spring City” Innovation and Excellence Labor Competition. Shandong Linuo Pharmaceutical Co., Ltd.’s Solid Dosage Form Workshop stood out among numerous outstanding work teams across the city thanks to its remarkable performance, rigorous work style, and exceptional innovative capabilities, earning the prestigious First Prize for Work Teams.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China